Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EssilorLuxottica | Parigi | Salute | Attrezzature e forniture medicali | 111,37 Mrd € | 46,4x | 47,89 | 241,40 € | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,1% Rialzo | Fai l’upgrade a Pro+ | |
Sanofi | Parigi | Salute | Prodotti farmaceutici | 100,88 Mrd € | 16,7x | 0,41 | 82,81 € | -2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 38,2% Rialzo | Fai l’upgrade a Pro+ | |
Sartorius Stedim | Parigi | Salute | Attrezzature e forniture medicali | 19,20 Mrd € | 93,6x | -4,13 | 197,05 € | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 22,5% Rialzo | Fai l’upgrade a Pro+ | |
Biomerieux | Parigi | Salute | Attrezzature e forniture medicali | 14,05 Mrd € | 32,4x | 1,55 | 118,80 € | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 6,7% Rialzo | Fai l’upgrade a Pro+ | |
Eurofins Scientific SE | Parigi | Salute | Ricerca medica e biotecnologica | 11,65 Mrd € | 33,3x | 0,75 | 60,50 € | -0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -8,6% Ribasso | Fai l’upgrade a Pro+ | |
Ipsen | Parigi | Salute | Prodotti farmaceutici | 8,44 Mrd € | 23,7x | -0,51 | 101,70 € | -1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,6% Rialzo | Fai l’upgrade a Pro+ | |
Virbac | Parigi | Salute | Prodotti farmaceutici | 2,67 Mrd € | 18,4x | 0,9 | 319 € | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 21,5% Rialzo | Fai l’upgrade a Pro+ | |
Emeis | Parigi | Salute | Fornitori e servizi sanitari | 1,76 Mrd € | -4,2x | 0,03 | 10,98 € | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 15,4% Rialzo | Fai l’upgrade a Pro+ | |
Clariane SE | Parigi | Salute | Fornitori e servizi sanitari | 1,63 Mrd € | -34,6x | -0,7 | 4,58 € | 1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -11,1% Ribasso | Fai l’upgrade a Pro+ | |
Ramsay Generale De Sante | Parigi | Salute | Fornitori e servizi sanitari | 1,22 Mrd € | -15,4x | 0,03 | 11,05 € | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Vetoquinol | Parigi | Salute | Prodotti farmaceutici | 828,06 Mln € | 14,2x | 2,4 | 70,20 € | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,6% Rialzo | Fai l’upgrade a Pro+ | |
Medincell | Parigi | Salute | Prodotti farmaceutici | 545,20 Mln € | -15,2x | 1,94 | 16,46 € | 9,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 33,7% Rialzo | Fai l’upgrade a Pro+ | |
Valneva | Parigi | Salute | Ricerca medica e biotecnologica | 413,60 Mln € | -4,5x | 0,03 | 2,43 € | -2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Inventiva | Parigi | Salute | Ricerca medica e biotecnologica | 400,26 Mln € | -0,9x | 0,08 | 2,88 € | 1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Boiron | Parigi | Salute | Prodotti farmaceutici | 394,12 Mln € | 34,8x | -0,51 | 22,70 € | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,9% Rialzo | Fai l’upgrade a Pro+ | |
Lumibird SA | Parigi | Salute | Attrezzature e forniture medicali | 338,94 Mln € | 58,8x | -2,84 | 15,40 € | 9,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -3,9% Ribasso | Fai l’upgrade a Pro+ | |
Abivax SA | Parigi | Salute | Ricerca medica e biotecnologica | 331,23 Mln € | -1,8x | -0,17 | 5,29 € | -6,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Euroapi | Parigi | Salute | Prodotti farmaceutici | 294,64 Mln € | -1,7x | -0,07 | 3,07 € | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -1,6% Ribasso | Fai l’upgrade a Pro+ | |
Amplitude Surgical SAS | Parigi | Salute | Attrezzature e forniture medicali | 292,62 Mln € | 305x | -2,76 | 6,10 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Guerbet | Parigi | Salute | Attrezzature e forniture medicali | 271,61 Mln € | 16,9x | -0,52 | 21,60 € | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 47,5% Rialzo | Fai l’upgrade a Pro+ | |
LNA Sante SA | Parigi | Salute | Fornitori e servizi sanitari | 257,67 Mln € | 11,9x | -1,74 | 25,20 € | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 22% Rialzo | Fai l’upgrade a Pro+ | |
Eurobio Scientific | Parigi | Salute | Ricerca medica e biotecnologica | 254,87 Mln € | 65,1x | -6,77 | 25,50 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,1% Rialzo | Fai l’upgrade a Pro+ | |
DBV Technologies SA | Parigi | Salute | Prodotti farmaceutici | 225,63 Mln € | -1,6x | 0,06 | 1,65 € | -3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -8,4% Ribasso | Fai l’upgrade a Pro+ | |
Bastide le Confort Medical | Parigi | Salute | Fornitori e servizi sanitari | 218,73 Mln € | 23,7x | -0,31 | 29,50 € | 2,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,7% Rialzo | Fai l’upgrade a Pro+ | |
Nanobiotix | Parigi | Salute | Ricerca medica e biotecnologica | 182,98 Mln € | -2,7x | 0,08 | 3,84 € | -5,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Genfit SA | Parigi | Salute | Ricerca medica e biotecnologica | 175,34 Mln € | 117,4x | 1,12 | 3,55 € | -1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Innate Pharma | Parigi | Salute | Ricerca medica e biotecnologica | 153,35 Mln € | -2,7x | 0,01 | 1,66 € | 1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Transgene | Parigi | Salute | Ricerca medica e biotecnologica | 122,96 Mln € | -3,2x | 0,12 | 0,93 € | -2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 49,6% Rialzo | Fai l’upgrade a Pro+ | |
Ose Pharma International SA | Parigi | Salute | Ricerca medica e biotecnologica | 116,28 Mln € | 3x | 0,01 | 5,09 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sensorion SA | Parigi | Salute | Ricerca medica e biotecnologica | 114,79 Mln € | -4,3x | -0,09 | 0,38 € | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |